Wan-Hua Ting

4PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 13, 2026
Feasibility and Safety of Repeated Intraperitoneal Platinum and Pegylated Liposomal Doxorubicin for First Recurrent Ovarian Cancer: A Preliminary Retrospective Comparative Study.

|Apr 23, 2022
Predictors for the Recurrence of Clinically Uterine-Confined Endometrial Cancer and the Role of Cytokeratin Immunohistochemistry Stain in the Era of Sentinel Lymph Node Mapping.

Wan-Hua Ting, Shu-Wei Hsieh, Hui-Hua Chen

|Aug 23, 2020
Predictors of Survival in Women with High-Risk Endometrial Cancer and Comparisons of Sandwich versus Concurrent Adjuvant Chemotherapy and Radiotherapy.

Hui-Hua Chen, Wan-Hua Ting, Hsu-Dong Sun

|May 24, 2020
Comparisons of Clinical Outcomes in Women with Advanced Ovarian Cancer Treated with Frontline Intraperitoneal versus Dose-Dense Platinum/Paclitaxel Chemotherapy without Bevacizumab.

Wan-Hua Ting, Chi-Huang Hsiao, Hui-Hua Chen

Pageof 1

Frequent Collaborators

4 joint publications

Hui-Hua Chen

4 joint publications

Sheng-Mou Hsiao